ConductScience.org, home

Paper4032403

Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis.

Smith MD and 2 others. J Rheumatol, 1985. Cited by 101 papers, by iCite.

Cite this record

ConductScience Library. Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis. Papers, record 4032403. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4032403

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis.
PubMed
Journal
J Rheumatol
PubMed
Year
1985
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
101
iCite
Relative citation ratio, by iCite
3.21
iCite
Revised in PubMed
2018-11-30
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Smith MDM D
2Gibson RAR A
3Brooks PMP M

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arthritis, RheumatoidMajor topic
Intestinal MucosaMajor topic
Spondylitis, AnkylosingMajor topic
Absorption
Adult
Aged
Anti-Inflammatory Agents
Female
Humans
Male
Middle Aged
Molecular Weight
Permeability
Polyethylene Glycols

Source PubMed

Download CSV of topics

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.

PMIDTitleJournalYearIn PapersSource
39534664Intestinal Permeability In Subjects With Rheumatoid Arthritis: A Critical Therapeutic Priority.Integr Med (Encinitas)2024https://conductscience.org/library/papers/39534664PubMed
37328529CXCL10 as a shared specific marker in rheumatoid arthritis and inflammatory bowel disease and a clue involved in the mechanism of intestinal flora in rheumatoid arthritis.Sci Rep2023https://conductscience.org/library/papers/37328529PubMed
36875067Brief report: Assessment of mucosal barrier integrity using serological biomarkers in preclinical stages of rheumatoid arthritis.Front Immunol2023https://conductscience.org/library/papers/36875067PubMed
36197645T cell Repertoire Profiling and the Mechanism by which HLA-B27 Causes Ankylosing Spondylitis.Curr Rheumatol Rep2022https://conductscience.org/library/papers/36197645PubMed
34296202Intestinal barrier dysfunction plays an integral role in arthritis pathology and can be targeted to ameliorate disease.Med2021https://conductscience.org/library/papers/34296202PubMed
33674813The gut-joint axis in rheumatoid arthritis.Nat Rev Rheumatol2021https://conductscience.org/library/papers/33674813PubMed
33396685The Role of Nutritional Factors and Intestinal Microbiota in Rheumatoid Arthritis Development.Nutrients2020https://conductscience.org/library/papers/33396685PubMed
31780866Effects of Anti-Cytokine Antibodies on Gut Barrier Function.Mediators Inflamm2019https://conductscience.org/library/papers/31780866PubMed
31292292Inflammatory arthritis disrupts gut resolution mechanisms, promoting barrier breakdown by Porphyromonas gingivalis.JCI Insight2019https://conductscience.org/library/papers/31292292PubMed
27428240Clinical features of Crohn disease concomitant with ankylosing spondylitis: A preliminary single-center study.Medicine (Baltimore)2016https://conductscience.org/library/papers/27428240PubMed
27002532Does the Microbiome Cause B27-related Acute Anterior Uveitis?Ocul Immunol Inflamm2016https://conductscience.org/library/papers/27002532PubMed
26370944The microbiome, HLA, and the pathogenesis of uveitis.Jpn J Ophthalmol2016https://conductscience.org/library/papers/26370944PubMed
19468992Gastrointestinal lesions associated with spondyloarthropathies.World J Gastroenterol2009https://conductscience.org/library/papers/19468992PubMed
17638132Dietary therapy with Lactobacillus GG, bovine colostrum or bovine immune colostrum in patients with juvenile chronic arthritis: evaluation of effect on gut defence mechanisms.Inflammopharmacology1997https://conductscience.org/library/papers/17638132PubMed
9486004Enhanced jejunal production of antibodies to Klebsiella and other Enterobacteria in patients with ankylosing spondylitis and rheumatoid arthritis.Ann Rheum Dis1997https://conductscience.org/library/papers/9486004PubMed
8835502HLA-B27 and bacteria.Clin Rheumatol1996https://conductscience.org/library/papers/8835502PubMed
7677438IgA1 and IgA2 subclass antibodies against Klebsiella pneumoniae in the sera of patients with peripheral and axial types of ankylosing spondylitis.Ann Rheum Dis1995https://conductscience.org/library/papers/7677438PubMed
3827333Circulating yersinia specific immune complexes after acute yersiniosis: a follow up study of patients with and without reactive arthritis.Ann Rheum Dis1987https://conductscience.org/library/papers/3827333PubMed
3592781Correlation of immunoglobulin and C reactive protein levels in ankylosing spondylitis and rheumatoid arthritis.Ann Rheum Dis1987https://conductscience.org/library/papers/3592781PubMed
3232256Salmonella reactive arthritis in established ankylosing spondylitis.Ulster Med J1988https://conductscience.org/library/papers/3232256PubMed

See all 28 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4032403

GET https://conductscience.org/api/papers/v1/4032403/cited_by?page=2